Luc Vittori

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +9

Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer

Guy Jérusalem, Angelica Fasolo, Véronique Dièras et al. · Breast Cancer Research and Treatment · 2010 · 140 citations

Medicine, Oncology, Pharmacology +16

The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI)

Marc Cohen, Gian Franco Gensini, Frans Maritz et al. · Journal of the American College of Cardiology · 2003 · 81 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Prospective Evaluation of Clinical Outcomes After Acute ST-Elevation Myocardial Infarction in Patients Who Are Ineligible for Reperfusion Therapy: Preliminary Results From the TETAMI Registry and Randomized Trial

Marc Cohen, Gian Franco Gensini, Frans Maritz et al. · Circulation · 2003 · 58 citations

Medicine, Cardiology, Pharmacotherapy +17

The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design

Marc Cohen, Frans Maritz, Gian Franco Gensini et al. · Journal of Thrombosis and Thrombolysis · 2000 · 25 citations

Medicine, Cardiology, Pharmacology +12